5 April 2018 EMA/543104/2014 Information Management

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide Maintenance operations: Update of an authorised medicinal product (AMP) entity in the XEVMPD

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

Table of contents 1.1. Example specifications .......................................................................................... 3 1.2. Retrieve the AMP entity ......................................................................................... 4 1.3. Create an XEVPRM ................................................................................................ 8 1.4. Validate and send an XEVPRM .............................................................................. 14 1.5. Retrieve the XEVPRM Acknowledgement (XEVPRM ACK) .......................................... 18

All examples used in this step-by-step guide are fictitious and intended for demonstration purposes only.

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 2/20

1.1. Example specifications For the purpose of this step-by-step exercise, you will be updating your previously submitted AMP with the name "Luna 21 PharmaL contraceptive tablets". The following information needs to be amended using operation type 'Update (2)': •

The authorisation procedure should be changed from "National Procedure" to " Mutual Recognition Procedure";



The MRP number "SE/H/0001/002" must be specified in the "MRP/DCP/EMEA number" field.

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 3/20

1.2. Retrieve the AMP entity 1) Log in to the requested EVWEB environment: EVWEB production:

https://eudravigilance.ema.europa.eu/x

XCOMP (test) environment:

https://evtest.ema.europa.eu/x

EVWEB training environment: https://eudravigilance-training.ema.europa.eu/x/

In the restricted area, click on "EVWEB":

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 4/20

You are now logged in EVWEB – the organisation ID under which you are logged in is shown in the top right corner:

2) Go to the "Medicinal Products" section and using the simple or advanced query, retrieve the specific product entry. Search for “Luna 21*” 

Please refer to the eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) Data-Entry Tool (EVWEB) User Manual, sections 4.2. Simple queries in the XEVMPD and 4.3. Advanced Queries in XEVMPD for information how to perform simple and advanced queries.

3) Select the medicinal product by ticking the relevant box in the active area:

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 5/20

The medicinal product is now displayed in the tree-view area:

4) Click on the product's name in the tree-view area:

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 6/20

The product details are displayed in the active area and the operation type buttons applicable for this AMP are also visible:

5) Click on operation type button "Update":

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 7/20

The AMP entity will be moved from the "Medicinal Products" section to the "Create and Send Product Reports" section:

1.3. Create an XEVPRM 1) By clicking on the area next to the "Message Number" (the area is highlighted in blue)with your mouse, clicking on the "E" (Text Edit) button or pressing "Enter" on your keyboard, the field will allow you to write the name you wish to assign to you XEVPRM :

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 8/20

2) Enter the name of your XEVPRM:

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 9/20

3) Click on the product's name in the tree-view area:

The active area will display the fields of your AMP: 

The "Operation type" field displays "Update (2)" as a default. It is not possible to assign a different operation type.

4) As per our specific example, click on the area next to the "Authorisation Procedure". The value of this field will be highlighted in blue:

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 10/20

The "Authorisation Procedure" field is a field that will allow you to select one of the pre-defined available values. Press "Enter" on your keyboard, double-click on the field, or click on the "R" (Remote look-up) button. The values available for this field will be displayed:

Using your mouse, select the requested value. It will become highlighted in black:

Once you click on the selected value, it will be displayed in the "Authorisation Procedure" field:

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 11/20

5) As per our specific example, click on the area next to "MRP/DCP/EMEA Number". The value of this field will be highlighted in blue:

The "MRP/DCP/EMEA Number" is a free-text field.

Press "Enter" on your keyboard or use the "E" ("Text Edit") button. Both actions will activate the field and allow you to write your text:

Type in the requested text and press "Enter" on your keyboard. The text will be displayed in the "MRP/DCP/EMEA Number" field:

You have now amended the fields as per our example specifications.

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 12/20

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 13/20

1.4. Validate and send an XEVPRM 1) Validate your XEVPRM by clicking with your mouse on the "Validate" button.

New window will be displayed on your screen, showing the result of your validation:

The section, where these errors occurred will be highlighted in red and/or the fields where information is missing will contain the text "Field is Mandatory"/"Field must have a specific value"/"Field is Mandatory Optional". Click on "OK" and the application will direct you to the first error. Enter/correct the required information:

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 14/20

Since we are performing an update of an AMP, as per the applicable business rules, we must specify that the referenced PPI attachment is still valid. The "Validity declaration" field is a field that will allow you to select one of the available pre-defined values. Using your mouse, click on the area next to "Validity declaration”. The area will become highlighted in blue:

Press "Enter" on your keyboard, double-click on the field, or click on the "R" (Remote look-up) button. The values available for this field will be displayed:

Using your mouse, select the requested value. Once you click on the selected value, it will be displayed in the "Validity declaration" field:

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 15/20

Validate the XEVPRM again.

You can dismiss the validation message by clicking on "OK". 2) Save the XEVPRM for your reference by selecting the relevant button:

3) Send the XEVPRM by clicking on the "Send" button. The below message will be displayed on your screen:

If you want to view/save your file, click on "OK".

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 16/20

The below message will be displayed, enabling you to save your XEVPRM file on your computer:

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 17/20

1.5. Retrieve the XEVPRM Acknowledgement (XEVPRM ACK) 1) Go to the "Web Trader" section

2) Click on "Inbox" (or "Archived Inbox" under "Archive", depending on when you decide to retrieve your XEVPRM ACK). The application will appear "frozen" for a second or two:

After a few seconds, the active area will display XEVPRM ACKs sent to your organisation's ID (the first message will be automatically highlighted in blue):

To view the ACK name in full, expand the section by placing your cursor on the separator line between "Name" and "Num/Count", click and drag towards the right until the full name is visible:

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 18/20

3) Based on the XEVPRM number, which you assigned to your message, find the XEVPRM ACK. Click on the relevant row with your mouse (the message will be highlighted in blue):

Press "Enter" on your keyboard or double-click with your mouse and the XML of the XEVPRM ACK will be displayed on your screen, showing the operation result and the assigned EVCode(s):

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 19/20

The update of your AMP was successful. 4) You can save the XML file of the XEVPRM ACK on your computer by going to "File" and selecting "Save As":

You have now successfully retrieved the XEVPRM Acknowledgement.

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide EMA/543104/2014

Page 20/20

eXtended EudraVigilance Medicinal Product Report Message ...

eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide. EMA/543104/2014. Page 3/20. 1.1. Example specifications.

1MB Sizes 38 Downloads 243 Views

Recommend Documents

eXtended EudraVigilance Medicinal Product Report Message ...
eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step. Guide. EMA/525101/2014. Page 5/83. You are now logged in EVWEB – the organisation ID under which you are logged in is shown in the top right corner: 2) Go to "Create an

eXtended EudraVigilance Medicinal Product Report Message ...
1) Log in to the requested EVWEB environment: EVWEB ...... 4) You can save the XML file of the XEVPRM ACK on your computer by going to "File" and selecting.

eXtended EudraVigilance Medicinal Product Report Message ...
Apr 5, 2018 - 1) Log in to the requested EVWEB environment: ...... on your keyboard or double-click with your mouse and the XML of the XEVPRM ACK.

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD ...
the field and allow you to write the name you wish to assign to you XEVPRM: 5) Type in the message number you wish to assign to your XEVPRM, then press "Enter" on your keyboard: 6) Expand the tree-view area by clicking on the "+" sign (see screenshot

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD ...
43 Winston Road. London. E14 5EU. UK. [email protected]. A sponsor organisation with the details: EraLab. Lockington Close. Margate. MA12 4JJ. UK.

eXtended EudraVigilance Medicinal Product Dictionary - European ...
Apr 5, 2018 - 4) Select the organisation which you wish to update by clicking inside the relevant box; the information for the MAH will be loaded in the tree view. 5) Click on the Organisation information corresponding to "Nobel Company" already load

eXtended EudraVigilance Medicinal Product Dictionary - European ...
Apr 5, 2018 - eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) Step-by-Step Guide. EMA/197297/2018. Page 6/9. 4) Click inside the box of the result (i.e. the AMP that you wish to invalidate); the information for the. AMP will be loaded i

Agenda and registration form - eXtended EudraVigilance medicinal ...
Bank transfers: When DIA completes your registration, an email will be ... complete the bank transfer. Payments in EURO ... 4051 Basel, Switzerland Web: www.

Agenda and registration form - eXtended EudraVigilance Medicinal ...
Signature. ATTENDEE DETAILS: Cancellation Policy. All cancellations must be made in writing and be ... and/or digital camera, to be used by DIA in promotional.

Agenda and registration form - eXtended EudraVigilance Medicinal ...
speakers are their own opinion and not necessarily that of the organisation they ... Please charge my ❑ VISA ❑ MC ❑ AMEX ... If you do not cancel four weeks prior to the event start ... materials, publications, and website and waive any and.

Medicinal product with a textile component
Jan 28, 2000 - structed in compact parallel bundles, whereas the meshwork .... spanned by a continuous thread 18 according to FIG. 3,. Which for example ...

Post-orphan medicinal product designation procedures: guidance
Jul 12, 2017 - page 6. - Information relating to Brexit under heading 9 added on ..... grounds that the paediatric indication brought a significant clinical benefit in comparison with existing ..... European Union, plus Icelandic and Norwegian.

Medicinal product with a textile component
Jan 28, 2000 - Foreign Application Priority Data. Feb. 4, 1999. (EP) . ... medical products such as wound compresses consist for example of woven fabric,.

EudraVigilance auditable requirement project -EudraVigilance ...
Jun 23, 2017 - Send a question via our website www.ema.europa.eu/contact ..... Guide to support users of the EVWEB application. NCAs, MAHs, ... developers.

2016 Annual Report on EudraVigilance for the European Parliament ...
Mar 16, 2017 - Annex II – EudraVigilance data-processing network and number of suspected ... Annex III - Total number of medicinal product submissions by MAHs ........... ..... the service and a workshop was held in September 2016 to obtain ...

2017 Annual Report on EudraVigilance for the European Parliament ...
Mar 15, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of ..... reports is shared between the NCAs as per the 'List of substances and products subject to worksharing ...... Lastly, in collaboration with Co

2016 Annual Report on EudraVigilance for the European Parliament ...
Mar 16, 2017 - ADR. Adverse Drug Reaction. CAP. Centrally Authorised Product. DHPC. Direct Healthcare Professional Communication. DME. Designated ...

2017 Annual Report on EudraVigilance for the European Parliament ...
Mar 15, 2018 - 7 http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2017/03/WC500222351.pdf. 8 Alvarez Y et al. Validation of statistical signal detection procedures in EudraVigilance post-authorization data: a r

EudraVigilance User Manual - Individual Case Safety Report form
Jan 22, 2018 - field in the form will be left blank. This to avoid the population of forms non-medically confirmed at case level when at least one reporter is a HCP. 3.6. Patient. This table contains information about the patient concerned in the cas

Non-animal approaches in support of medicinal product development ...
Oct 5, 2017 - Nature Review drug Discovery 3, 711-715. Hornberg et al 2014. Drug Discovery Today 19; 1131-1136. Most noted safety reasons for withdrawal of marketed drugs: •. Liver toxicity. •. Cardiovascular toxicity. •. CNS effects. Main reas

Non-animal approaches in support of medicinal product development ...
Oct 5, 2017 - Non-animal approaches in support of ... Cardiovascular toxicity >>> CNS, lung, adapative immune system ... for regulatory decision making.

Paediatric strategy forum for medicinal product development of
Apr 17, 2018 - Paediatric Strategy Forum for Medicinal Product Development of Checkpoint inhibitors for use in combination therapy in paediatric patients. EMA/242738/2018. Page 3/4. List of speakers and moderators. To be announced ...

Watertown Extended Day Report FINAL (1).pdf
Program Site Coordinator at the J.R. Lowell School. Page 3 of 86. Watertown Extended Day Report FINAL (1).pdf. Watertown Extended Day Report FINAL (1).

MESSAGE
your labor from long years of acquiring basic knowledge and skills from your dear Alma Mater. Let me be with you' giving ... ardor and diligence. Don't be scared.